Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vivani Medical, Inc.VANI · Entity 6636 | Chief Business Officer | July 28, 2026 | July 31, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vivani Medical, Inc.
Report date July 28, 2026 · Filed July 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.31 · Expires 2036-07-27 | Direct | 70,000 |
Reported balance
After 2026-07-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-28 · Grant · Acquired 70,000 · Balance 70,000 F1: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. |
| RSUsSEC Table II · derivative / convertible security | Direct | 35,000 |
Reported balance
After 2026-07-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-28 · Grant · Acquired 35,000 · Balance 35,000 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock. F3: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.
F3: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2026 Filed Jul 31, 2026 00:27 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRSUs · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-26-001286 · form4.xml · derivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock. F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. Read SEC document |
| July 28, 2026 Filed Jul 31, 2026 00:27 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 70,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001753926-26-001286 · form4.xml · derivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2036-07-27 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| May 12, 2025 Filed May 15, 2025 00:38 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRSUs · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-25-000831 · form4.xml · derivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock. F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. Read SEC document |
| May 12, 2025 Filed May 15, 2025 00:38 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 70,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001753926-25-000831 · form4.xml · derivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2035-05-11 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| April 01, 2025 Filed Apr 1, 2025 23:00 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 4,000 | $1.03 | $4,100.00 |
DisclosureSEC source: 0001753926-25-000555 · primary_doc.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 00:23 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 1,000 | $1.11 | $1,110.00 |
DisclosureSEC source: 0001753926-25-000392 · primary_doc.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,000 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| October 03, 2024 Filed Oct 3, 2024 22:10 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 500 | $1.13 | $565.00 |
DisclosureSEC source: 0001753926-24-001643 · primary_doc.xml · nonDerivative · entry 3 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 22:10 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 1,000 | $1.13 | $1,130.00 |
DisclosureSEC source: 0001753926-24-001643 · primary_doc.xml · nonDerivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:10 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 1,000 | $1.14 | $1,140.00 |
DisclosureSEC source: 0001753926-24-001643 · primary_doc.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 00:40 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 4,000 | $1.23 | $4,920.00 |
DisclosureSEC source: 0001753926-24-001335 · primary_doc.xml · nonDerivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| July 30, 2024 Filed Aug 2, 2024 00:40 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 5,000 | $1.24 | $6,200.00 |
DisclosureSEC source: 0001753926-24-001335 · primary_doc.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| May 10, 2024 Filed May 14, 2024 22:51 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRestricted Stock Units · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-24-000965 · ownership.xml · derivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock. F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. Read SEC document |
| May 10, 2024 Filed May 14, 2024 22:51 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 70,000 | $0.00 Strike: $1.81 | $0.00 |
DisclosureSEC source: 0001753926-24-000965 · ownership.xml · derivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2034-05-09 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| November 22, 2023 Filed Nov 22, 2023 22:04 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 1,000 | $0.96 | $960.00 |
DisclosureSEC source: 0001753926-23-001531 · ownership.xml · nonDerivative · entry 3 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| November 22, 2023 Filed Aug 2, 2024 00:27 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 2,000 | $0.96 | $1,920.00 |
DisclosureSEC source: 0001753926-24-001334 · primary_doc.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 22:04 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 2,000 | $0.96 | $1,920.00 |
DisclosureSEC source: 0001753926-23-001531 · ownership.xml · nonDerivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 22:04 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 2,500 | $0.96 | $2,400.00 |
DisclosureSEC source: 0001753926-23-001531 · ownership.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| September 27, 2023 Filed Sep 27, 2023 23:53 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 1,000 | $1.01 | $1,010.00 |
DisclosureSEC source: 0001753926-23-001275 · ownership.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 23:06 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 7,500 | $0.94 | $7,050.00 |
DisclosureSEC source: 0001753926-23-001192 · ownership.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 18:43 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 7,500 | $1.08 | $8,100.00 |
DisclosureSEC source: 0001753926-23-001082 · ownership.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 15:03 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 5,000 | $1.24 | $6,200.00 |
DisclosureSEC source: 0001753926-23-000850 · ownership.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:36 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRSUs · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000267 · ownership.xml · derivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock. F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:36 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRSUs · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000267 · ownership.xml · derivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock. F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 02:09 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 70,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-23-000078 · ownership.xml · derivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2033-01-19 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 02:09 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 30,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-23-000078 · ownership.xml · derivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-01-19 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 16:11 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 5,000 | $1.40 | $7,000.00 |
DisclosureSEC source: 0001753926-22-001490 · ownership.xml · nonDerivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · kind: Individual purchased shares on the open market Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 16:11 UTC | Vivani Medical, Inc. VANI · Entity 6636 | PurchaseCommon Stock | 5,000 | $1.50 | $7,500.00 |
DisclosureSEC source: 0001753926-22-001490 · ownership.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · kind: Individual purchased shares on the open market Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:24 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock Option · Derivative | 36,224 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001184 · ownership.xml · derivative · entry 3 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,224 Underlying: Common Stock · 36,224 shares Expires 2031-02-27 F1 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:24 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock Option · Derivative | 217,344 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001184 · ownership.xml · derivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,344 Underlying: Common Stock · 217,344 shares Expires 2030-11-09 F1 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. F2 · shares: The option vests monthly in equal parts over the three years after the date of grant commencing November 1, 2020. F2 · balance_after: The option vests monthly in equal parts over the three years after the date of grant commencing November 1, 2020. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:24 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock Option · Derivative | 36,224 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001184 · ownership.xml · derivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,224 Underlying: Common Stock · 36,224 shares Expires 2029-11-11 F1 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.